Zeta Surgical has launched a collaboration with DARPA to advance robotic, neuronavigated transcranial magnetic stimulation that can be delivered in a single day.
Transcranial magnetic stimulation is an established treatment for depression and other neurological conditions, but it depends on placing the coil precisely over the right cortical target and holding it there across a full session. That precision requirement limits who can deliver the therapy and how efficiently it can be scheduled.
Zeta builds image-guided robotics for neurosurgery and already holds FDA clearance for a robotic TMS navigation system. The DARPA work aims to combine that neuronavigation with robotic positioning to compress treatment into one day rather than the weeks of repeated visits the standard protocol requires.
The company has not disclosed the value of the agreement or a timeline.
The collaboration adds to a growing federal interest in robotics and AI for neurological care, including recent FDA action on a surgical robot TMS system.
